(function(){var loadHandler=window['sl_{5FF308B2-B98A-4E74-8B64-E86D41BD2B1E}'];loadHandler&&loadHandler(21, '<div id="spr0_449c5f"><div id="spr1_449c5f" class="kern"><img id="img0_449c5f" src="data/img2.png" width="810px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_449c5f" class="kern"><div id="svg0_449c5f" style="left:-1.5px;top:41.25px;"><svg width="812" height="58" viewBox="-1.5 -1.5 812 58"><path fill="#00279f" stroke="#ffffff" stroke-width="1" stroke-linecap="butt" stroke-linejoin="miter" stroke-miterlimit="8" d="M0.5,0.5 h808 v53.375 h-808 Z"/></svg></div><div id="spr3_449c5f" style="top:42.75px;"><div style="width:0px;"><span id="txt0_449c5f" class="nokern" data-width="528.257813" style="left:141.313px;top:18.114px;">HOW  many passes if on site cytologic evaluation is not available?</span></div><div style="width:0px;"><span id="txt1_449c5f" class="nokern" data-width="528.257813" style="left:140.5px;top:17.301px;">HOW  many passes if on site cytologic evaluation is not available?</span></div></div><div id="spr4_449c5f" style="left:54px;top:138px;"><div style="width:0px;"><span id="txt2_449c5f" class="nokern relpos" style="left:8.187px;top:5.333px;">•</span><span id="txt3_449c5f" class="nokern relpos" data-width="641.464844" style="left:28.31px;top:5.519px;">In submucosal tumors, the accuracy of EUS-FNA increased gradually with each</span></div><div style="width:0px;"><span id="txt4_449c5f" class="nokern" data-width="439.267578" style="left:35.312px;top:29.519px;">consequent pass to reach a plateau after the fourth pass</span></div><div style="width:0px;"><span id="txt5_449c5f" class="nokern relpos" style="left:7.313px;top:4.46px;">•</span><span id="txt6_449c5f" class="nokern relpos" data-width="641.464844" style="left:27.436px;top:4.645px;">In submucosal tumors, the accuracy of EUS-FNA increased gradually with each</span></div><div style="width:0px;"><span id="txt7_449c5f" class="nokern" data-width="439.267578" style="left:34.438px;top:28.645px;">consequent pass to reach a plateau after the fourth pass</span></div><div style="width:0px;"><span id="txt8_449c5f" class="nokern relpos" style="left:8.187px;top:67.733px;">•</span><span id="txt9_449c5f" class="nokern relpos" data-width="630.439453" style="left:28.31px;top:67.919px;">A  retrospective study, 112  upper GI subepithelial lesions. EUS-FNA, over all</span></div><div style="width:0px;"><span id="txt10_449c5f" class="nokern" data-width="624.462891" style="left:35.312px;top:91.919px;">diagnostic yield of 83.9%, :high diagnostic yield was obtained with a mean of</span></div><div style="width:0px;"><span id="txt11_449c5f" class="nokern" data-width="131.113281" style="left:35.312px;top:115.919px;">5.3 FNA passes.</span></div><div style="width:0px;"><span id="txt12_449c5f" class="nokern relpos" style="left:7.313px;top:66.86px;">•</span><span id="txt13_449c5f" class="nokern relpos" data-width="630.439453" style="left:27.436px;top:67.045px;">A  retrospective study, 112  upper GI subepithelial lesions. EUS-FNA, over all</span></div><div style="width:0px;"><span id="txt14_449c5f" class="nokern" data-width="624.462891" style="left:34.438px;top:91.045px;">diagnostic yield of 83.9%, :high diagnostic yield was obtained with a mean of</span></div><div style="width:0px;"><span id="txt15_449c5f" class="nokern" data-width="131.113281" style="left:34.438px;top:115.045px;">5.3 FNA passes.</span></div><div style="width:0px;"><span id="txt16_449c5f" class="nokern relpos" style="left:8.187px;top:154.133px;">•</span><span id="txt17_449c5f" class="nokern relpos" data-width="631.933594" style="left:28.31px;top:154.319px;">In a Japanese study. 141 patients, a mean of 2.5 ± 0.7 passes with 22-G needle,</span></div><div style="width:0px;"><span id="txt18_449c5f" class="nokern" data-width="633.867188" style="left:35.312px;top:178.319px;">sample adequacy of 83%, better for lesions &gt;2 cm than for those with a smaller</span></div><div style="width:0px;"><span id="txt19_449c5f" class="nokern" data-width="74.960938" style="left:35.312px;top:202.319px;">diameter.</span></div><div style="width:0px;"><span id="txt20_449c5f" class="nokern relpos" style="left:7.313px;top:153.26px;">•</span><span id="txt21_449c5f" class="nokern relpos" data-width="631.933594" style="left:27.436px;top:153.445px;">In a Japanese study. 141 patients, a mean of 2.5 ± 0.7 passes with 22-G needle,</span></div><div style="width:0px;"><span id="txt22_449c5f" class="nokern" data-width="633.867188" style="left:34.438px;top:177.445px;">sample adequacy of 83%, better for lesions &gt;2 cm than for those with a smaller</span></div><div style="width:0px;"><span id="txt23_449c5f" class="nokern" data-width="74.960938" style="left:34.438px;top:201.445px;">diameter.</span></div></div></div></div>');})();